Industry News
BetaStay ahead with AI-powered media monitoring and human quality assurance. Our curated industry insights give you a comprehensive overview of the latest developments in your field
Local & industry wins build trusted proof, SEO signals, and prime national editors.
Flow Neuroscience, a company based in Malmö, has secured FDA premarket approval for their electric brain stimulation headset, which treats depression. U.S. clinics can now prescribe this headset for adult patients with moderate to severe major depressive disorder, making it the first FDA-approved at-home medical device for this purpose.
Photo by Nick Fewings on Unsplash
50 articles found
Cenova, a Mjölby-based company, has transformed from a component manufacturer to a strategic development and manufacturing partner in medical technology, prompting expansion due to increasing market demand. This includes scaling production, implementing automation, and planning a new manufacturing facility to capitalize on opportunities in the evolving medical technology field.
Photo by ZHENYU LUO on Unsplash
GE Healthcare unveiled its Photonova Spectra CT scanner at RSNA in Chicago, featuring Deep Silicon detector technology. The scanner offers exceptional spectral and spatial resolution for ultra-high-resolution imaging with broad coverage and is based on technology from Sweden. GE Healthcare has submitted a pre-market notification for the Photonova Spectra in the United States.
Photo by Enrico Fumagalli on Unsplash
GE Healthcare unveiled the Photonova Spectra CT system at RSNA, utilizing "Deep Silicon" photon-counting detectors initially created in Sweden. This new system aims to deliver ultra-high-resolution imaging due to its superior spectral and spatial resolution. GE Healthcare has also filed a premarket notification in the U.S. for the device.
Photo by Rosen Stoyanov on Unsplash
Swedish investment firm Amplex launched a SEK 1.05 billion public takeover bid for life science company Addvise Group, aiming to delist it from the stock exchange, according to Medtech Magazine. Amplex's offer, at SEK 1.65 per share and SEK 0.49 per warrant, signifies a 42% premium over Addvise's recent valuation.
Photo by Vitaly Gariev on Unsplash
Survey of PR challenges among 314 Nordic startup and scaleup companies.
Read the reportMark Waugh will become OssDsign's CEO starting January 1, 2026, joining from Medacta USA where he was SVP – Commercial. With over 20 years in orthopedics from companies like Smith & Nephew and Medtronic, Waugh will work from OssDsign's U.S. office and his home in Indiana, concentrating on U.S. market growth.
Photo by Navy Medicine on Unsplash
Mark Waugh will become the new CEO of OssDsign AB, starting January 1, 2026, succeeding Morten Henneveld. Waugh, previously with Medacta USA and other firms, brings extensive experience to OssDsign, operating from the U.S. to drive growth in America and Europe.
Photo by Navy Medicine on Unsplash
Suturion, a Swedish medical device company, has received CE marking for its surgical suturing device intended for abdominal wall closure after surgery. With this regulatory approval secured, Suturion is now cleared to commercially launch and distribute the device throughout the European market, offering its advanced surgical solution to healthcare providers in the region.
Photo by Sakarie Mustafe Hidig on Unsplash
Optisense Care created the Zen Seat, a smart toilet seat equipped with radar, to monitor bowel habits in elderly and dementia care facilities. The Zen Seat tracks emptying patterns to inform caregivers about patient health. Helsingborg will be the first city to officially test the Zen Seat's effectiveness.
Photo by Kelsey Todd on Unsplash
Philips is expanding the commercial availability of its Lumiguide 3D Device Guidance technology in Europe and the U.S. Lumiguide, integrated into the Azurion platform, is the first light-based system for real-time navigation within the body, offering a radiation-free alternative to X-ray imaging for minimally invasive procedures.
Photo by Craig Cameron on Unsplash
Trelleborg, an industrial group, has expanded its focus on medical technology and biopharmaceuticals by opening three new facilities globally. These facilities are dedicated to serving these industries. *Medtech Magazine* reports that Trelleborg, a global industrial group, has recently opened three new facilities worldwide dedicated to medical technology and biopharmaceuticals. These investments follow the formation of...
Photo by Galen Crout on Unsplash
Anna Lefevre Skjöldebrand, CEO of Swedish Medtech, stated in a December 8, 2025 interview that increased digitalization and advancements in precision diagnostics will cause more healthcare delivery to occur within patients' homes. She also noted that geopolitical factors, preparedness, and global competitiveness will influence the medtech industry's evolution alongside internal innovations.
Photo by Vitaly Gariev on Unsplash
TL;DR: Cellavision has secured CE marking for its Bone Marrow Aspirate (BMA) Application, designed for use with Cellavision's DC-1 instrument. The software solution is intended for clinical laboratories to automate and standardize the morphological analysis of bone marrow samples, aiding in the assessment of blood abnormalities.
Photo by Harpreet Singh on Unsplash
Anna Maria Braun is the CEO of B. Braun Melsungen, a medical device company founded in 1839, and owns 10% of the company. Under her father's leadership, the company grew from $24 million in annual sales to $8 billion and employs over 64,000 people globally, offering infusion solutions, surgical instruments, and other technologies.
Photo by Peter Poluch on Unsplash
Torben Nielsen is resigning as President and CEO of Boule Diagnostics, a role he began in April 2024. Nielsen led a restructuring that cut costs, stopped in-house hematology instrument development, shifted to a partner-based portfolio, and altered financial reporting to segment the company into Diagnostics and OEM Clinical Diagnostic Solutions.
Photo by Malcolm Choong 鍾声耀 on Unsplash
Medtech Magazine is releasing industry profiles with executive insights on past performance and future strategies, looking ahead to 2026. A deeper strategic analysis is not yet available, as the full content will be published after the holidays. Medtech Magazine has released a preview of its upcoming industry profiles, featuring insights from leading executives regarding their expectations for 2026. The profiles will explore leaders' perspectives on both past performance and future strategies. Further strategic analysis is unavailable at this time, pending the release of the full content following the holiday season.
Photo by BoliviaInteligente on Unsplash
Tove Christiansson is now the CEO of Careium, according to Medtech Magazine. Christiansson is also Chairman of Swedish Medtech and currently leads the Hjälpmedel business area within the Medcap Group, where she serves as CEO of a portfolio company. According to Medtech Magazine, Tove Christiansson has been named the new Chief Executive Officer of Careium. Christiansson also serves as Chairman of Swedish Medtech and currently leads the Hjälpmedel business area within the Medcap Group, where she is also CEO of a portfolio company. Specifics regarding Careium's strategic objectives for this.
Photo by Marco Bicca on Unsplash
Tove Christiansson, the current Chair of Swedish Medtech, will become Careium's CEO in Q2 2026, succeeding the interim CEO in place since August. Christiansson brings experience from Medcap, including her role as Head of Aids and CEO of Abilia, and is recognized by Careium's Chairman as a commercially-driven leader with expertise in the welfare technology sector and M&A-driven growth.
Photo by Markus Winkler on Unsplash
RISE MNB's article highlights strategies for manufacturers to expedite MDR certification, achieving it in 6-9 months compared to the 12-18 month average. They attribute faster certification to proactive strategies like integrating regulatory compliance early in product development and actively engaging in open communication with notified bodies throughout the process.
Photo by Dimitri Karastelev on Unsplash
Pernilla Norman writes in Medtech Magazine that the EU's "digital decade" legislation, including the "omnibus package" intended to simplify administrative processes, could paradoxically increase complexity for medtech companies through revisions to the GDPR and the AI Act. Multiple acts like the Digital Markets Act, Digital Services Act, NIS2 Directive, Data Act, and Cyber Resilience Act may create an increasingly complex regulatory environment, which could undermine the EU's simplification goal.
Photo by Milad Fakurian on Unsplash
Addlife, through its Labtech business, acquired Danish companies Pharmacold A/S and Opitek International ApS, according to Medtech Magazine. Pharmacold, specializing in temperature-controlled storage, will be integrated into Addlife's Holm & Halby subsidiary to broaden their product portfolio and offerings. Addlife, a company known for strategic acquisitions, has further expanded its Labtech business area with the acquisition of Danish companies Pharmacold A/S and Opitek International ApS, according to Medtech Magazine. The acquisition of Pharmacold A/S, a specialist in temperature-controlled storage solutions for the pharmaceutical and healthcare industries, represents a key strategic.
Photo by Jeff Trierweiler on Unsplash
Magloy Tech, a Singaporean medtech startup founded by Manakari, Parande, and Professor Gupta, created OrthoMag, a biocompatible magnesium alloy bone implant. Designed to dissolve over time, OrthoMag eliminates the need for a second surgery to remove it, leading to reduced patient risk, with Magloy Tech also receiving funding from firms such as Origgin Ventures and Startup SG Tech.
Photo by TSD Studio on Unsplash
TL;DR: Getinge CEO Mattias Perjos stated in Medtech Magazine that Liberation Day's new tariffs and currency fluctuations are challenging the medtech industry, potentially threatening patient access to crucial healthcare solutions. Simultaneously, artificial intelligence and digitalization are rapidly transforming operational practices in both healthcare and medtech.
Photo by EqualStock on Unsplash
Sweden proposes amending the Freedom of the Press Act and the Fundamental Law on Freedom of Expression to comply with the EU's accessibility directive. This will broaden accessibility requirements for products and services protected under media constitutional laws, including e-books and e-commerce, with an effective date of January 1, 2027.
Photo by Annie Spratt on Unsplash
Swedish healthcare faces persistent inefficiencies, as reported by Catharina Barkman in Medtech Magazine. Reviews confirm issues with managing medical referrals, leading to misplacement, delays, redundant testing, and increased costs. Barkman highlights the lack of tracking for referrals, akin to package delivery, revealing communication breakdowns that impede timely patient care.
Photo by Kristine Wook on Unsplash
Surgical Science's stock plummeted by over 60% after Intuitive Surgical ended an agreement to integrate their simulation software into all new Da Vinci 5 robots. Intuitive Surgical now intends to offer Surgical Science's software to select clients only and include their own simulation package in the remaining Da Vinci 5 systems, impacting the market's perception of Surgical Science.
Photo by Natanael Melchor on Unsplash
Elekta, a medical tech firm, will cut around 450 jobs globally, as revealed in their report on Wednesday, November 26, 2025. This restructuring follows underperformance despite market advantages and a relevant product line, impacting management positions. According to a report in Medtech Magazine, Elekta, a medical technology company, is implementing a restructuring plan that will eliminate approximately 450 positions worldwide. The announcement, included in the company's quarterly report released on Wednesday, November 26, 2025, cited underperformance relative to its potential despite operating within a favorable market and possessing a pertinent.
Photo by Lightsaber Collection on Unsplash
Claes Lindahl, Intellego Technologies' ex-CEO, has been detained due to heightened suspicion of aggravated fraud, according to a Stockholm District Court ruling. The investigation, led by State Prosecutor Thomas Hertz, is scrutinizing Intellego's public communications since 2025 to ascertain if investors were intentionally misled regarding the company's market value. Nasdaq is also in the process of delisting Intellego Technologies from the First North exchange.
Photo by Jonathan Gong on Unsplash
Paradromics received FDA approval for clinical trials of their Connexus brain chip, designed to restore speech for individuals with severe communication disabilities. The Investigational Device Exemption allows Paradromics to begin early-stage human trials of their brain-computer interface, positioning them as a competitor with Neuralink and Synchron in the neurotechnology industry.
Photo by Natasha Connell on Unsplash
Veronica Arthurson, currently a Director at the Swedish Medical Products Agency, has been appointed Health and Medical Care Director for Region Norrbotten, Sweden, no later than May 2026. Region Director Ulrika Sundquist cited Arthurson’s background in pharmaceutical matters and emergency preparedness as key reasons for her selection, with Arthurson noting the unique challenges of providing healthcare in the region.
Photo by Andreas Eriksson on Unsplash
Gustaf Salford, previously CEO of Elekta, is now CEO of Ratos, an industrial group. He left Elekta in March after five years due to performance not meeting expectations and is now transitioning out of medtech, as Ratos possesses a diverse portfolio employing around 11,000 people in sectors like construction, technology, and infrastructure.
Photo by Armin Iranzad on Unsplash
Philips and Edwards Lifesciences have launched Device Guide AI, an advancement built on Philips' Echo Navigator platform. Medtech Magazine reports the AI offers cardiologists a virtual 3D model of the heart to provide real-time visualization and guidance, improving precision during mitral and tricuspid valve procedures by enhancing device tracking and support during surgery.
Photo by Georg Eiermann on Unsplash
Intellego Technologies CEO Claes Lindahl was arrested November 18, 2025, by Swedish authorities investigating suspected gross fraud. Simultaneously, the company's offices were raided, and a "kvarstad" seizure order was imposed, freezing 100 million Swedish kronor of their assets. Claes Lindahl, CEO of Intellego Technologies, was arrested on November 18, 2025, by the Swedish Economic Crime Authority as part of a preliminary investigation into suspected gross fraud. Medtech Magazine reported that authorities also raided the company's premises on the same day. In addition to the arrest, investigators executed search warrants and.
Photo by Vishnu Mohanan on Unsplash
Cochlear's Mölnlycke headquarters in Sweden is reorganizing, leading to job cuts. Between 20 and 30 positions are expected to be eliminated following internal communication in October, impacting the workforce of 219 Swedish employees, though the specific number is still under negotiation.
Photo by Mark Paton on Unsplash
Cochlear's Swedish headquarters in Mölnlycke is undergoing reorganization, confirmed by CEO Adi Nilsson, involving union negotiations. While Cochlear has not disclosed specific numbers, an earlier report estimates 20 to 30 positions may be affected, although the company has not confirmed this.
Photo by Mark Paton on Unsplash
Social Minister Jakob Forssmed is being awarded Forska Sverige's politician prize for his work in improving health data usage. Secretary-General Anna Nilsson Vindefjärd credits Forssmed and the government for starting important national strategies for health data, acknowledging the challenges involved in this area.
Photo by Arthur Hinton on Unsplash
Siemens will spin off 30% of its Siemens Healthineers division to existing shareholders, relinquishing its controlling stake. Siemens will retain a significant minority ownership position in Healthineers after the transaction, which confirms earlier speculation about the strategic move. Siemens AG has officially announced the planned spin-off of a substantial portion of its Siemens Healthineers division. According to the company's press release, Siemens will distribute 30% of its Healthineers shares to existing Siemens shareholders. This transaction will result in Siemens relinquishing its controlling stake in Healthineers while retaining a significant minority.
Photo by National Cancer Institute on Unsplash
Essity is acquiring Edgewell Personal Care's women's health business for $1 billion, which includes the Carefree, Stayfree, and o.b. brands in the U.S., the Playtex brand globally, and a Delaware production facility. The deal brings 500 employees to Essity and strengthens the company's position in the North American hygiene and health market.
Photo by EqualStock on Unsplash
Post-market surveillance is a critical tool for patient safety, regulatory compliance, and continuous improvement, extending beyond simple complaint handling. The EU MDR mandates a proactive PMS approach, requiring integration with risk management and communication with regulators for safeguarding patients and company viability.
Photo by Kristine Wook on Unsplash
Physiotherapist Kajsa Undin created a digital support application to solve widespread issues regarding Medical Device Regulation (MDR) compliance within healthcare facilities. Undin, as Medically Responsible for Rehabilitation, noticed significant failures in tracking and controlling medical devices over three years in both private and municipal care settings, leading her to develop the innovative application.
Photo by Tim Witzdam on Unsplash
Synchron secured $200 million to commercialize its Stentrode brain-computer interface, a less invasive technology designed to allow paralyzed individuals to control digital devices with their thoughts. The Stentrode, currently undergoing clinical trials in the U.S. and Australia with ten patients, aims to offer a safer alternative to open-brain surgery.
Photo by Bhautik Patel on Unsplash
Get daily industry insights via newsletter. Optionally join the beta for full access to all Heartspace modules.
Get curated industry insights delivered to your inbox. Choose your sectors of interest.
Whether you prefer DIY tools or done-for-you services, we can help you get media coverage.